From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients
Benedicte Grebstad Tune(Oslo University Hospital), Yafeng Ma(Camden and Campbelltown Hospitals), Geoffrey McCowage(Children's Hospital at Westmead), Smadar Kahana‐Edwin(Children's Hospital at Westmead), Eng‐Siew Koh(Liverpool Hospital), Joseph W. Po(Camden and Campbelltown Hospitals), Jonathan Karpelowsky(The University of Sydney), Victoria Prior(The University of Sydney), Maria Tsoli(Cancer Institute of New South Wales), Lars O. Baumbusch(Oslo University Hospital), Cheok S. Lee(Camden and Campbelltown Hospitals), Heena Sareen(UNSW Sydney), David S. Ziegler(Cancer Institute of New South Wales), Tara L. Roberts(Camden and Campbelltown Hospitals), Therese M. Becker(Liverpool Hospital), Lucy E. Cain(Children's Hospital at Westmead), Geraldine M. O’Neill(The University of Sydney), Mark Dexter(Children's Hospital at Westmead), Adam Cooper(Liverpool Hospital), Paul DeSouza(Camden and Campbelltown Hospitals), Branka Powter(Ingham Institute)
Cited by 2
Related Papers
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
|Journal of Clinical Oncology|2018|433
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
|Nature Genetics|2013|332